Enliven Therapeutics (ELVN) Tax Provisions (2024)
Enliven Therapeutics' (ELVN) quarterly Tax Provisions came in at $232000.0 in Q2 2024.
Enliven Therapeutics (ELVN) Tax Provisions (2024) Analysis & Trends
Enliven Therapeutics has disclosed Tax Provisions across 1 years of filings, most recently posting $232000.0 for Q2 2024.
- Tax Provisions for Q2 2024 came in at $232000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $232000.0 (changed N/A YoY), and the FY2024 annual result was $232000.0, changed N/A from the prior year.
- Tax Provisions came in at $232000.0 for Q2 2024 at Enliven Therapeutics.
- In the past five years, Tax Provisions ranged from a high of $232000.0 in Q2 2024 to a low of $232000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Enliven Therapeutics | 2.32 Bn | 2.32 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 232,000.00 |